ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.517,31
-0,45%
S&P 500
5.631,22
0,28%
Dow Jones
40.211,72
0,53%
Euro vs US Dollar
1,09029
0,03%
Bitcoin
63.412,48
-2,22%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Opiant Pharmaceuticals Inc (OPNT)

  7. Opiant Pharmaceuticals Inc (OPNT) News

OPNT

Opiant Pharmaceuticals (OPNT)

Opiant Pharmaceuticals Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:OPNT
DatumZeitQuelleÜberschriftSymbolFirma
09/11/201122h57Edgar (US Regulatory)Amended Quarterly Report (10-Q/A)NASDAQ:OPNTOpiant Pharmaceuticals Inc
09/11/201122h27Edgar (US Regulatory)Current report filing (8-K)NASDAQ:OPNTOpiant Pharmaceuticals Inc
09/11/201122h05GlobeNewswire Inc.OPNET Announces Special Dividend Set at $0.85 Per ShareNASDAQ:OPNTOpiant Pharmaceuticals Inc
09/11/201122h05GlobeNewswire Inc.OPNET Announces Record Financial Results for Second Quarter of Fiscal 2012NASDAQ:OPNTOpiant Pharmaceuticals Inc
02/11/201114h30Business WireLightlake Therapeutics Inc. Announces Fiscal 2011 Year End ResultsNASDAQ:OPNTOpiant Pharmaceuticals Inc
31/10/201122h48PR Newswire (US)S&P Indices Announces Changes to U.S. IndicesNASDAQ:OPNTOpiant Pharmaceuticals Inc
31/10/201122h24Edgar (US Regulatory)Annual Report (10-K)NASDAQ:OPNTOpiant Pharmaceuticals Inc
27/10/201118h06Edgar (US Regulatory)Current report filing (8-K)NASDAQ:OPNTOpiant Pharmaceuticals Inc
06/10/201122h31GlobeNewswire Inc.OPNET Technologies, Inc. Schedules Fiscal 2012 Second Quarter Results Teleconference/Webcast for Wednesday, November 9, 2011NASDAQ:OPNTOpiant Pharmaceuticals Inc
05/10/201114h50Business WireLightlake Therapeutics Inc. to Conduct Phase II Testing of New Bulimia Nervosa Treatment at King’s College LondonNASDAQ:OPNTOpiant Pharmaceuticals Inc
21/09/201122h40GlobeNewswire Inc.OPNET Recognized in the "Leaders" Quadrant of the Magic Quadrant for Application Performance MonitoringNASDAQ:OPNTOpiant Pharmaceuticals Inc
16/09/201122h05Edgar (US Regulatory)Current report filing (8-K)NASDAQ:OPNTOpiant Pharmaceuticals Inc
13/09/201120h43Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OPNTOpiant Pharmaceuticals Inc
13/09/201120h35Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OPNTOpiant Pharmaceuticals Inc
13/09/201120h29Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OPNTOpiant Pharmaceuticals Inc
10/09/201100h59Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OPNTOpiant Pharmaceuticals Inc
10/09/201100h50Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OPNTOpiant Pharmaceuticals Inc
06/09/201122h15GlobeNewswire Inc.OPNET to Present at Kaufman Bros. 14th Annual Investor ConferenceNASDAQ:OPNTOpiant Pharmaceuticals Inc
01/09/201114h45GlobeNewswire Inc.OPNET Introduces Smart Phone App to Remotely Access End-User Experience MonitoringNASDAQ:OPNTOpiant Pharmaceuticals Inc
31/08/201115h00MarketwiredIndustry Outlook, Reliance on Global State - Equity Research on OPNET Technologies, Inc. and NetScout Systems, Inc.NASDAQ:OPNTOpiant Pharmaceuticals Inc
31/08/201114h40GlobeNewswire Inc.OPNET Introduces Breakthrough Solution for Managing Application Performance in Citrix EnvironmentsNASDAQ:OPNTOpiant Pharmaceuticals Inc
30/08/201115h03GlobeNewswire Inc.OPNET Unveils Capabilities for Managing Application Performance in the CloudNASDAQ:OPNTOpiant Pharmaceuticals Inc
29/08/201114h55GlobeNewswire Inc.Announcing OPNETWORK 2011NASDAQ:OPNTOpiant Pharmaceuticals Inc
25/08/201121h07Edgar (US Regulatory)Current report filing (8-K)NASDAQ:OPNTOpiant Pharmaceuticals Inc
24/08/201116h06Business WireLightlake Therapeutics Inc. Set to Begin Phase II Clinical Trials of Binge Eating Disorder TreatmentNASDAQ:OPNTOpiant Pharmaceuticals Inc
10/08/201118h56Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OPNTOpiant Pharmaceuticals Inc
08/08/201119h49Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OPNTOpiant Pharmaceuticals Inc
08/08/201119h41Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OPNTOpiant Pharmaceuticals Inc
05/08/201122h06Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:OPNTOpiant Pharmaceuticals Inc
04/08/201123h20Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OPNTOpiant Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:OPNT

Kürzlich von Ihnen besucht

USOTC
ADDYY
Adidas (QX)
NYSE
NKE
Nike
TG
NOV
Novo Nordisk
TG
MBG
MercedesBenz
CCOM
US500
US 500
CCOM
US100
US Tech 100
TG
TUI1
Tui
NASDAQ
MSFT
Microsoft
TG
LHA
Deutsche Lufthansa
NYSE
KO
Coca Cola
USOTC
RHHBY
Roche (QX)
USOTC
BNPQY
BNP Paribas (QX)
DBI
MDAX
MDAX
NASDAQ
AMZN
Amazon.com
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten